Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2-metastatic breast cancer

Elie El Rassy; Pamela Abdayem; Joseph Kattan

doi:10.2217/fon-2017-0190

Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2-metastatic breast cancer

Elie El Rassy, Pamela Abdayem, Joseph Kattan

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

1 Citation (Scopus)

langue originale	Anglais
Pages (de - à)	1451-1453
Nombre de pages	3
journal	Future Oncology
Volume	13
Numéro de publication	17
Les DOIs	https://doi.org/10.2217/fon-2017-0190
état	Publié - 1 juil. 2017
Modification externe	Oui

Accès au document

10.2217/fon-2017-0190

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{57b1fea66cfc453e96cde4a1a795aa14,

title = "Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2-metastatic breast cancer",

keywords = "CDK4/6 inhibitor, metastatic breast cancer, mTOR inhibitors, second line",

author = "{El Rassy}, Elie and Pamela Abdayem and Joseph Kattan",

year = "2017",

month = jul,

day = "1",

doi = "10.2217/fon-2017-0190",

language = "English",

volume = "13",

pages = "1451--1453",

journal = "Future Oncology",

issn = "1479-6694",

number = "17",

}

TY - JOUR

T1 - Circumvent hesitancy between CDK4/6 and mTOR inhibitors in second-line treatment of HR+, erb2-metastatic breast cancer

AU - El Rassy, Elie

AU - Abdayem, Pamela

AU - Kattan, Joseph

PY - 2017/7/1

Y1 - 2017/7/1

KW - CDK4/6 inhibitor

KW - metastatic breast cancer

KW - mTOR inhibitors

KW - second line

UR - http://www.scopus.com/inward/record.url?scp=85027036581&partnerID=8YFLogxK

U2 - 10.2217/fon-2017-0190

DO - 10.2217/fon-2017-0190

M3 - Review article

C2 - 28685610

AN - SCOPUS:85027036581

SN - 1479-6694

VL - 13

SP - 1451

EP - 1453

JO - Future Oncology

JF - Future Oncology

IS - 17

ER -